The ankle-brachial blood pressure index (ABPI) has been recognized to have a predictive value for cardiovascular (CV) events and mortality in general or dialysis populations. However, the associations ...

The ankle–brachial blood pressure index (ABI) is a simple and non-invasive measure to assess the patency of the arteries of the lower extremities, and predicts cardiovascular morbidity and mortality.

March 16, 2010 (Tampa, Florida) — An abnormal ankle-brachial index (ABI) can predict an increased risk for future cardiovascular events in elderly people with low to intermediate Framingham Risk ...

Assessing CVD risk with ankle-brachial index The American Heart Association issues guidance for assessing CVD risk using ABI. As one of the least expensive and most available markers of ...

DALLAS, Texas — A new scientific statement from the American Heart Association is intended to standardize the measurement and interpretation of the ankle-brachial index (ABI) [1]. The statement is ...

Low ankle-brachial index (ABI), even when too borderline to be considered peripheral artery disease, is associated with diminished quality of life (QoL) in terms of physical functioning, impaired ...

Dear Dr. Roach: I’m an 88-year-old woman in good health except that I have had a lot of leg and back pain in the past two or so years. I had spinal stenosis, and I have arthritis as well. A vascular ...

Systolic blood pressure is measured by Doppler ultrasonography in each arm and in the dorsalis pedis (DP) and posterior tibial (PT) arteries in each ankle. The higher of the two arm pressures is ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

VOL: 101, ISSUE: 04, PAGE NO: 47Julia Graham, RGN, community staff nurse/vascular link nurse, Arran War Memorial Hospital, Lamlash, Isle of ArranBackground Subscribe today to access over 6,000 ...

We have moved Diagnostics guidance 52 to become HealthTech guidance 677. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, ...